| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $99,681,239 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 001 | 4 | NIH | 3/13/2026 | $16,798 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 4 | NIH | 1/30/2026 | $531,931 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA061324 | Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH).” | 000 | 3 | NIH | 5/29/2026 | $598,161 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30EY035154 | Combining OCE and Brillouin microscopy to evaluate in vivo lens biomechanics in Presbyopia | 000 | 4 | NIH | 1/20/2026 | $54,538 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122777 | Targeting mitochondrial Complex I in neonatal hypoxia-ischemia | 001 | 5 | NIH | 3/5/2026 | $51,063 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122777 | Targeting mitochondrial Complex I in neonatal hypoxia-ischemia | 000 | 5 | NIH | 2/5/2026 | $459,576 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK130238 | Pharmacogenetics of the Response to a GLP1R Agonist | 000 | 5 | NIH | 12/4/2025 | $672,063 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129310 | Behavioral and neural mechanisms mediating social motivation in a rat model for ASD | 000 | 4 | NIH | 2/6/2026 | $412,962 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 001 | 3 | NIH | 4/17/2026 | $64,113 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 000 | 3 | NIH | 12/22/2025 | $577,013 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 002 | 3 | NIH | 6/10/2026 | $108,736 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 001 | 4 | NIH | 3/27/2026 | $65,182 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 000 | 4 | NIH | 1/23/2026 | $586,642 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162940 | Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation | 001 | 4 | NIH | 3/24/2026 | $15,386 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162940 | Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation | 000 | 4 | NIH | 2/6/2026 | $487,205 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK074797 | Inter-organ signaling in heme metabolism and organismal homeostasis. | 000 | 15 | NIH | 12/30/2025 | $397,410 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01AI196239 | Host-pathogen-microbiome interactions in Mycoplasma genitalium infection, pathology, and treatment: experiments in a 3D organotypic cervical epithelium model to strengthen clinical guidelines | 000 | 1 | NIH | 4/24/2026 | $155,893 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH139606 | Quantifying cerebellar multi-omic and synaptic features of autism spectrum disorders | 000 | 1 | NIH | 3/9/2026 | $762,566 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25AG088402 | Entrepreneurship & Science Communication for Aging and Aging-related Research (ESCAAR) Program for Doctoral Students and Postdoctoral Scholars | 000 | 2 | NIH | 6/5/2026 | $262,873 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG092405 | HCN Channels Mediate Olfactory Dysfunction in Aging and Neurological Disease | 000 | 1 | NIH | 2/18/2026 | $649,766 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31AA032134 | Targeting prefrontostriatal circuits to rescue alcohol-induced behavioral inflexibility | 000 | 1 | NIH | 4/17/2026 | $40,624 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31AA032134 | Targeting prefrontostriatal circuits to rescue alcohol-induced behavioral inflexibility | 001 | 1 | NIH | 4/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA301173 | Associations between actigraphy-derived circadian rest-activity rhythms and cancer-related fatigue: Insights from the Harvest for Health Clinical Trial | 000 | 1 | NIH | 3/18/2026 | $411,334 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA065079 | Impact of opioid use disorder on mitochondrial dysfunction among antiretroviral therapy-receiving aging people with HIV. | 000 | 1 | NIH | 3/10/2026 | $685,937 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI199072 | Modeling Bordetella pertussis infection and immunity in human nasal organoids | 000 | 1 | NIH | 5/12/2026 | $194,375 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI190325 | Epigenetic regulation of neo-sex chromosomes in filarial parasites | 000 | 1 | NIH | 4/16/2026 | $440,211 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F32AI200207 | Menstrual phase targeted therapy: a novel strategy to improve clearance and reduce recurrence of bacterial vaginosis | 000 | 1 | NIH | 5/7/2026 | $79,764 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F32AI200207 | Menstrual phase targeted therapy: a novel strategy to improve clearance and reduce recurrence of bacterial vaginosis | 001 | 1 | NIH | 5/7/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99CA312671 | Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparison | 000 | 1 | NIH | 5/7/2026 | $123,823 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI192916 | Shark nanobodies identify pan-coronavirus spike sites of vulnerability fortherapeutic intervention | 000 | 1 | NIH | 5/6/2026 | $896,045 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI196307 | Modeling the Vaginal Microbiome: Predicting BV Recurrence and Identifying Preventative Targets | 000 | 1 | NIH | 4/6/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 002 | 1 | NIH | 3/25/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 001 | 1 | NIH | 2/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30DA065321 | Characterizing the novel activity of THC directly at the androgen receptor on masculinization of the brain | 000 | 1 | NIH | 2/6/2026 | $48,290 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | S10OD040129 | 120kV Transmission Electron Microscope | 000 | 1 | NIH | 5/15/2026 | $674,156 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI198875 | Host-pathogen-microbiome interactions in Mycoplasma genitalium pathology and treatment: experiments in a 3D organotypic cervical epithelium model to strengthen clinical guidelines | 000 | 1 | NIH | 6/10/2026 | $194,375 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA302901 | Protein Degradation Strategies to Overcome Menin Drug Resistance in Acute Leukemias | 000 | 1 | NIH | 5/15/2026 | $399,829 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AG095506 | Instrumented brain organoids transplantation for chronic stroke treatment | 000 | 1 | NIH | 5/15/2026 | $649,688 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | DP2AI192747 | Gut Microbial Protein Metabolism in Food Allergy and Oral Immunotherapy Efficacy | 000 | 1 | NIH | 1/28/2026 | $466,500 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R00NS134734 | Dynamics of Hippocampal Inputs in Alzheimer's Disease | 000 | 3 | NIH | 3/6/2026 | $248,936 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | RF1AG059651 | PROMIS Profile Measures for Older Adults with Cognitive Impairment-Developing Versions for Older Adults with Cognitive Impairment and for Proxy Completion | 000 | 6 | NIH | 4/29/2026 | $3,284,905 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | RF1AG059651 | PROMIS Profile Measures for Older Adults with Cognitive Impairment-Developing Versions for Older Adults with Cognitive Impairment and for Proxy Completion | 001 | 6 | NIH | 6/8/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01EY038421 | Development, Refinement, and Validation of Sensitive and Robust AO-OCT Glaucoma Biomarkers | 000 | 1 | NIH | 4/29/2026 | $571,206 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI190371 | Multi-omics Analysis of Bacteria-Host Interactions in Brugia malayi, a Medically Important Nematode with a Wolbachia Endosymbiont | 000 | 1 | NIH | 3/27/2026 | $678,218 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS141786 | SGLT2 - Novel Molecular Mechanism of AQP4 Regulation | 000 | 1 | NIH | 3/5/2026 | $602,065 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03DE035988 | Citrate regulation in amelogenesis | 000 | 1 | NIH | 6/11/2026 | $311,000 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | S10OD040102 | High-Throughput Automated Patch Clamp Instrument | 000 | 1 | NIH | 5/1/2026 | $750,000 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI196697 | A cord-blood specific subset of human gamma-delta T cells with distinct functional features | 000 | 1 | NIH | 2/3/2026 | $455,500 |
| | 2026 | 2026 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG089369 | Normalized cerebrovascular reactivity MRI in small-vessel-disease (SVD) related cognitive impairment | 000 | 1 | NIH | 1/20/2026 | $589,154 |
|
